Products
TransPlus Virus Transduction Enhancer
Optimized for the infection of lentivirus or retrovirus to most cells
Have questions? Contact us
TransPlus™ Virus Transduction Enhancer is a mixture of polymers optimized for the infection of lentivirus or retrovirus to most cells. It can increase the transduction rate up to 10 fold. TransPlus is provided as a 500x solution, sufficient for 100 transductions in a 24 well plate. It is intended for retroviral or lentiviral transduction.
| Product Name | TransPlus Virus Transduction Enhancer |
|---|---|
| Shipping Condition |
Room Temperature - 2 Day Shipping |
| Storage and Stability |
This product is stable for 3 months when stored in 4 °C or 6 months if store at -20 °C. |
| Quality Control | Each lot of TransPlus Virus Transduction Enhancer is tested for sterility and successful increase in transduction efficiency of viral particles. |
| Restricted Use |
For Research Use Only. Not for use in diagnostic or therapeutic procedures. |
- V. Golubovskaya et al., CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth. Cancers (Basel), 10 (2017)
- R. Berahovih et al., FLAG-tagged CD19-specific CAR-T cells eliminate CD19-bearing solid tumor cells in vitro and in vivo. Front Biosci (Landmark Ed), 22 (2017)
- Liu S. et al., Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection. Front Immunol (2024)
- Vidal M.S. Jr. et al., Establishment and comparison of human term placenta–derived trophoblast cells. Biol Reprod (2023)
Have Questions?
If you don't see the product you're looking for, please don't hesitate to CONTACT US. Our dedicated team of scientists will provide you our best solutions for your desired results.